TY  - CONF

T1  - A pharmacokinetic-pharmacodynamic model to explain the biphasic insulinergic effect of tolbutamide and the suppressive role of lowering blood glucose on this effect

JO  - BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

PY  - 1996/11/01

AU  - RostamiHodjegan A

AU  - Peacey SR

AU  - Heller SR

AU  - Tucker GT

ED  - 

VL  - 42

IS  - 5

SP  - P675

EP  - P676

Y2  - 2024/12/22

ER  -